Back to company

CAND.PHARM. POVL M. ASSENS FOND: Financial statements 2018

CVR: 14536604

CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 0 and a net result of DKK -1,737,723 compared with DKK 5,195,201 the year before. Equity amounted to DKK 98,905,351. The solvency ratio was 98.6%. The company had 36 employees in the financial year.

Revenue
0 kr.
Gross Profit
0 kr.
Profit/Loss
-1,737,723 kr.
Equity
98,905,351 kr.
Total Assets
100,287,173 kr.
Employees
36

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201800-1.7 mio.98.9 mio.36
2017005.2 mio.101.6 mio.32
2016005.1 mio.97.2 mio.29
2015006.2 mio.89.2 mio.31
2014006.9 mio.86.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CAND.PHARM. POVL M. ASSENS FOND

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

CAND.PHARM. POVL M. ASSENS FOND: The 2017 annual report is outMay 9, 2018

CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 5,195,201.

About CAND.PHARM. POVL M. ASSENS FOND

CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.